162 related articles for article (PubMed ID: 35699228)
21. Perivascular epithelioid cell tumor (PEComa) of the urinary bladder associated with Xp11 translocation.
Russell CM; Buethe DD; Dickinson S; Sexton WJ
Ann Clin Lab Sci; 2014; 44(1):91-8. PubMed ID: 24695481
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous PEComa does not harbour TFE3 gene fusions: immunohistochemical and molecular study of 17 cases.
Llamas-Velasco M; Mentzel T; Requena L; Palmedo G; Kasten R; Kutzner H
Histopathology; 2013 Jul; 63(1):122-9. PubMed ID: 23711163
[TBL] [Abstract][Full Text] [Related]
23. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction.
Malinowska I; Kwiatkowski DJ; Weiss S; Martignoni G; Netto G; Argani P
Am J Surg Pathol; 2012 May; 36(5):783-4. PubMed ID: 22456611
[No Abstract] [Full Text] [Related]
24. TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.
Hyrcza MD; Winer DA; Shago M; Au K; Zadeh G; Asa SL; Mete O
Endocr Pathol; 2017 Mar; 28(1):22-26. PubMed ID: 27189222
[TBL] [Abstract][Full Text] [Related]
25. Primary Mesenchymal Tumors of the Thyroid Gland: A Modern Retrospective Cohort Including the First Case of TFE3-Translocated Malignant Perivascular Epithelioid Cell Tumor (PEComa).
Zhang L; Lubin D; Sinard JH; Dickson BC; Antonescu CR; Wu H; Panni RZ; Dogan S; Untch BR; Ghossein RA; Xu B
Head Neck Pathol; 2022 Sep; 16(3):716-727. PubMed ID: 35218514
[TBL] [Abstract][Full Text] [Related]
26. Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.
Caliò A; Brunelli M; Gobbo S; Pedron S; Segala D; Argani P; Martignoni G
Pathology; 2021 Aug; 53(5):579-585. PubMed ID: 33461798
[TBL] [Abstract][Full Text] [Related]
27. A renal epithelioid angiomyolipoma/perivascular epithelioid cell tumor with TFE3 gene break visualized by FISH.
Ohe C; Kuroda N; Hes O; Michal M; Vanecek T; Grossmann P; Tanaka Y; Tanaka M; Inui H; Komai Y; Matsuda T; Uemura Y
Med Mol Morphol; 2012 Dec; 45(4):234-7. PubMed ID: 23224603
[TBL] [Abstract][Full Text] [Related]
28. Ocular PEComas are frequently melanotic and TFE3-translocated: report of two cases including the first description of PRCC-TFE3 fusion in PEComa.
Gao Y; Chen G; Chow C; Io I; Wong EWN; Tsui WMS; Lam WY; To KF; Chan JKC; Cheuk W
Virchows Arch; 2021 May; 478(5):1025-1031. PubMed ID: 32676967
[TBL] [Abstract][Full Text] [Related]
29. Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.
Bennett JA; Braga AC; Pinto A; Van de Vijver K; Cornejo K; Pesci A; Zhang L; Morales-Oyarvide V; Kiyokawa T; Zannoni GF; Carlson J; Slavik T; Tornos C; Antonescu CR; Oliva E
Am J Surg Pathol; 2018 Oct; 42(10):1370-1383. PubMed ID: 30001237
[TBL] [Abstract][Full Text] [Related]
30. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor.
Wangsiricharoen S; Ingram DR; Morey RR; Wani K; Lazar AJ; Wang WL
Mod Pathol; 2024 Mar; 37(3):100426. PubMed ID: 38219952
[TBL] [Abstract][Full Text] [Related]
31. Malignant perivascular epithelioid cell tumor of the lung synchronous with a primary adenocarcinoma: one case report and review of the literature.
Zhao J; Teng H; Zhao R; Ding W; Yu K; Zhu L; Zhang J; Han Y
BMC Cancer; 2019 Mar; 19(1):235. PubMed ID: 30876389
[TBL] [Abstract][Full Text] [Related]
32. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
33. Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 Cases.
de la Fouchardiere A; Papke DJ; Pissaloux D; Russell-Goldman E; Tirode F; Fletcher CDM; Hanna J
Am J Surg Pathol; 2024 Jan; 48(1):88-96. PubMed ID: 38117287
[TBL] [Abstract][Full Text] [Related]
34. PEComa: morphology and genetics of a complex tumor family.
Thway K; Fisher C
Ann Diagn Pathol; 2015 Oct; 19(5):359-68. PubMed ID: 26144278
[TBL] [Abstract][Full Text] [Related]
35. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
[TBL] [Abstract][Full Text] [Related]
36. Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.
McGregor SM; Alikhan MB; John RA; Kotler H; Bridge JA; Mujacic I; Kadri S; Segal J; Krausz T
Am J Surg Pathol; 2017 May; 41(5):717-722. PubMed ID: 28009605
[TBL] [Abstract][Full Text] [Related]
37. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
[TBL] [Abstract][Full Text] [Related]
38. Soft Tissue Perivascular Epithelioid Cell Tumors.
Hammer PM; Tan SY
Surg Pathol Clin; 2024 Mar; 17(1):105-118. PubMed ID: 38278600
[TBL] [Abstract][Full Text] [Related]
39. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract][Full Text] [Related]
40. Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNA.
Akumalla S; Madison R; Lin DI; Schrock AB; Yakirevich E; Rosenzweig M; Balar AV; Frampton GM; Edgerly C; Erlich RL; Miller VA; Ganesan S; Ross JS; Ali SM
Oncology; 2020; 98(12):905-912. PubMed ID: 32966992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
